CN Stock MarketDetailed Quotes

600557 Jiangsu Kanion Pharmaceutical

Watchlist
  • 14.28
  • -0.08-0.56%
Not Open Nov 28 15:00 CST
8.31BMarket Cap15.26P/E (TTM)

Jiangsu Kanion Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
21.60%1.82B
4.80%2.07B
38.88%2.05B
22.98%1.97B
25.93%1.49B
106.54%1.98B
104.09%1.47B
70.82%1.6B
52.10%1.19B
43.71%957.36M
Transactional financial assets
-54.23%325M
15.38%210M
122.77%450M
170.59%460M
162.96%710M
-19.11%182M
-31.53%202M
-3.41%170M
84.93%270M
100.89%225M
Notes receivable and accounts receivable
-1.13%652.71M
-1.54%654.06M
-2.45%695.44M
-10.22%653.77M
-14.12%660.18M
-12.58%664.32M
-11.33%712.93M
-0.52%728.22M
-8.73%768.71M
-19.41%759.91M
-Accounts receivable
-1.13%652.71M
-1.54%654.06M
-2.45%695.44M
-10.22%653.77M
-14.12%660.18M
-12.58%664.32M
-11.33%712.93M
-0.52%728.22M
-8.73%768.71M
-19.41%759.91M
Other receivables (including interest and dividends)
-64.14%2.84M
-2.88%12.06M
2.88%13.74M
-45.02%5.32M
-44.86%7.93M
-8.43%12.41M
16.68%13.35M
-17.70%9.67M
5.35%14.38M
6.16%13.55M
-Other receivable
----
-2.88%12.06M
----
----
----
-8.43%12.41M
----
-17.70%9.67M
----
6.16%13.55M
Advance payment
-48.02%44.36M
-5.64%41.93M
-45.61%25.43M
-52.69%28.63M
99.95%85.35M
12.79%44.43M
-35.78%46.75M
86.49%60.51M
-1.64%42.69M
-27.03%39.39M
Inventories
51.16%546.13M
48.71%503.53M
7.42%395.82M
2.13%350.11M
52.56%361.3M
21.37%338.61M
31.85%368.47M
1.40%342.82M
-29.34%236.82M
-18.40%278.99M
Receivable financing
8.15%335.48M
-38.60%334.49M
-34.54%537.03M
-40.44%442.23M
-45.62%310.19M
-14.66%544.79M
23.26%820.42M
20.15%742.52M
28.90%570.37M
22.61%638.41M
Assets held for sale
----
----
----
--67.04M
----
----
----
----
----
----
Other current assets
252.94%6.68M
846.76%72.21M
16.59%58.59M
-1.94%73.36M
124.21%1.89M
901.16%7.63M
432.27%50.25M
162.82%74.81M
-79.70%844.36K
-81.17%761.79K
Total current assets
2.73%3.73B
3.42%3.9B
14.50%4.22B
8.58%4.05B
17.50%3.63B
29.45%3.77B
28.95%3.69B
29.77%3.73B
18.53%3.09B
9.75%2.91B
Non Current assets
Other non-current financial assets
-40.15%11.21M
-56.18%11.21M
-64.12%11.21M
-73.00%11.21M
-63.36%18.73M
-51.64%25.58M
-44.79%31.24M
-26.63%41.52M
-13.36%51.11M
-10.34%52.89M
Long-term equity investment
0.14%4.11M
0.14%4.11M
0.51%4.11M
0.51%4.11M
1.01%4.11M
1.01%4.11M
1.02%4.09M
1.02%4.09M
0.46%4.07M
0.46%4.07M
Fixed assets
----
-6.01%2.22B
----
----
----
-0.72%2.36B
----
-1.66%2.41B
----
-4.91%2.38B
Constru in process
----
111.37%283.85M
----
----
----
1.91%134.29M
----
18.86%98.54M
----
325.12%131.76M
Intangible assets
-20.57%170.35M
-18.22%176.82M
-15.12%190.31M
-14.61%197.38M
-10.13%214.47M
-18.83%216.22M
-18.33%224.2M
-18.24%231.15M
-17.74%238.66M
-18.01%266.37M
Development expenditure
9.36%181.5M
5.21%177.59M
3.66%172.77M
3.09%171.7M
4.86%165.96M
7.73%168.8M
9.78%166.67M
10.22%166.56M
6.98%158.27M
7.14%156.68M
Goodwill
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
Long deferred expense
-21.03%12.07M
-20.01%12.85M
-20.37%13.62M
-21.01%14.4M
-8.26%15.28M
-8.76%16.06M
-10.18%17.11M
-8.92%18.23M
-20.65%16.66M
-19.91%17.6M
Deferred tax assets
56.72%43.04M
70.51%47.12M
236.25%50.61M
189.67%46.22M
64.89%27.46M
69.07%27.64M
-8.76%15.05M
-4.82%15.96M
-2.67%16.65M
-7.39%16.35M
Other non current assets
422.54%105.7M
619.92%164.56M
616.51%157.45M
156.97%55.6M
237.42%20.23M
178.91%22.86M
29.12%21.97M
4.42%21.63M
-67.45%6M
-48.51%8.2M
Total non current assets
3.52%3.17B
3.99%3.15B
4.19%3.16B
0.05%3.07B
0.05%3.06B
-1.80%3.03B
-3.03%3.03B
-2.48%3.07B
-2.54%3.06B
-2.81%3.09B
Total assets
3.09%6.9B
3.67%7.05B
9.85%7.38B
4.73%7.12B
8.81%6.7B
13.37%6.8B
12.25%6.72B
12.92%6.8B
7.01%6.15B
2.91%6B
Liabilities
Current liabilities
Short term loan
----
----
----
----
----
----
----
----
--0
----
Notes payable and accounts payable
-28.87%145.27M
0.26%230.93M
-14.79%253.75M
-38.82%228.42M
-35.42%204.24M
-22.17%230.34M
6.10%297.81M
3.79%373.36M
-3.82%316.24M
-0.05%295.97M
-Notes payable
----
----
----
----
----
-52.70%7.5M
-49.36%11.27M
-69.73%11.86M
-59.34%17.94M
-42.75%15.85M
-Accounts payable
-28.87%145.27M
3.63%230.93M
-11.44%253.75M
-36.81%228.42M
-31.53%204.24M
-20.45%222.84M
10.87%286.54M
12.77%361.5M
4.78%298.31M
4.35%280.11M
Contract liabilities
12.82%15.61M
-36.70%18.55M
-65.65%16.1M
-88.29%25.17M
-33.31%13.84M
29.67%29.31M
188.94%46.87M
748.11%214.87M
49.70%20.75M
8.90%22.61M
Salaries payable
-44.88%18.08M
-51.67%12.49M
-60.74%8M
-34.04%25.73M
28.50%32.8M
29.47%25.84M
64.52%20.38M
60.22%39M
36.80%25.53M
39.86%19.95M
Taxs payable
7.05%75.79M
-22.25%52.9M
106.35%59.58M
-23.56%70.67M
8.36%70.8M
-11.40%68.04M
-23.76%28.87M
84.04%92.44M
28.88%65.34M
202.13%76.79M
Other payable (including interest and dividends)
6.52%1.18B
-1.13%1.24B
18.37%1.37B
19.88%1.24B
26.82%1.11B
55.27%1.26B
36.46%1.16B
36.81%1.03B
34.73%872.98M
11.55%809.75M
-Dividend payable
----
----
----
----
----
--128.61M
----
----
----
----
-Other payable
----
10.13%1.24B
----
----
----
39.39%1.13B
----
36.81%1.03B
----
11.55%809.75M
Hold and for sell liabilities
----
----
----
--16.55M
----
----
----
----
----
----
Other current liabilities
12.92%2.02M
-36.86%2.4M
-65.77%2.09M
-88.34%3.26M
-33.58%1.79M
29.18%3.8M
188.94%6.09M
748.11%27.93M
49.70%2.7M
8.90%2.94M
Total current liabilities
0.39%1.44B
-3.36%1.56B
9.79%1.71B
-9.68%1.61B
9.75%1.43B
31.48%1.61B
19.16%1.56B
22.59%1.78B
0.56%1.3B
-11.63%1.23B
Current liabilities
Long term account payable
----
--0
----
----
----
--0
----
--0
----
--0
Specific account payable
----
0.00%1.93M
----
----
----
0.00%1.93M
----
0.00%1.93M
----
0.00%1.93M
Long term deferred income
68.26%128.92M
100.74%156.51M
98.08%154.57M
60.14%126.16M
-12.49%76.62M
-11.06%77.97M
-12.94%78.03M
-12.97%78.78M
-3.69%87.55M
-4.55%87.66M
Total non current liabilities
66.59%130.84M
98.31%158.43M
95.72%156.5M
58.70%128.08M
-12.22%78.54M
-10.83%79.89M
-12.67%79.96M
-12.70%80.71M
-3.62%89.48M
-4.46%89.59M
Total liabilities
3.83%1.57B
1.43%1.72B
13.97%1.87B
-6.72%1.74B
8.34%1.51B
28.61%1.69B
17.08%1.64B
20.48%1.86B
0.28%1.39B
-11.18%1.32B
Shareholders equity
Paid-in capital
-0.48%581.8M
-0.48%581.8M
0.03%584.75M
0.03%584.75M
0.00%584.6M
1.42%584.6M
1.42%584.6M
-1.40%584.6M
-1.40%584.6M
-2.77%576.43M
Capital reserve funds
-23.85%92.96M
-23.85%92.96M
13.92%111.79M
13.92%111.79M
47.47%122.07M
365.07%122.07M
273.86%98.13M
-42.88%98.13M
-52.58%82.78M
-84.96%26.25M
Surplus reserve funds
0.00%292.81M
0.00%292.81M
0.00%292.81M
0.00%292.81M
0.00%292.81M
0.00%292.81M
0.00%292.81M
-5.79%292.81M
-5.79%292.81M
-5.79%292.81M
Retained profit
8.08%4.39B
7.78%4.3B
10.41%4.4B
10.62%4.25B
10.14%4.06B
10.23%3.99B
13.24%3.98B
12.75%3.84B
11.98%3.69B
11.46%3.62B
Less:Treasury stock
224.73%210.09M
85.48%120M
-3.78%62.26M
-25.60%48.14M
0.00%64.7M
--64.7M
--64.7M
-64.06%64.7M
-64.06%64.7M
----
Shareholders equity without minority interests
3.02%5.15B
4.53%5.15B
8.81%5.33B
9.23%5.19B
9.01%5B
9.07%4.93B
10.90%4.9B
10.45%4.75B
9.34%4.59B
7.86%4.52B
Minority interests
-1.10%185.59M
1.29%186.99M
0.75%182.64M
4.43%187.76M
7.25%187.67M
9.50%184.61M
7.43%181.27M
6.80%179.8M
4.52%174.98M
3.91%168.59M
Total shareholder equity
2.87%5.34B
4.42%5.34B
8.52%5.51B
9.05%5.38B
8.95%5.19B
9.09%5.11B
10.77%5.08B
10.31%4.93B
9.16%4.76B
7.71%4.68B
Total liabilityies and equity
3.09%6.9B
3.67%7.05B
9.85%7.38B
4.73%7.12B
8.81%6.7B
13.37%6.8B
12.25%6.72B
12.92%6.8B
7.01%6.15B
2.91%6B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 21.60%1.82B4.80%2.07B38.88%2.05B22.98%1.97B25.93%1.49B106.54%1.98B104.09%1.47B70.82%1.6B52.10%1.19B43.71%957.36M
Transactional financial assets -54.23%325M15.38%210M122.77%450M170.59%460M162.96%710M-19.11%182M-31.53%202M-3.41%170M84.93%270M100.89%225M
Notes receivable and accounts receivable -1.13%652.71M-1.54%654.06M-2.45%695.44M-10.22%653.77M-14.12%660.18M-12.58%664.32M-11.33%712.93M-0.52%728.22M-8.73%768.71M-19.41%759.91M
-Accounts receivable -1.13%652.71M-1.54%654.06M-2.45%695.44M-10.22%653.77M-14.12%660.18M-12.58%664.32M-11.33%712.93M-0.52%728.22M-8.73%768.71M-19.41%759.91M
Other receivables (including interest and dividends) -64.14%2.84M-2.88%12.06M2.88%13.74M-45.02%5.32M-44.86%7.93M-8.43%12.41M16.68%13.35M-17.70%9.67M5.35%14.38M6.16%13.55M
-Other receivable -----2.88%12.06M-------------8.43%12.41M-----17.70%9.67M----6.16%13.55M
Advance payment -48.02%44.36M-5.64%41.93M-45.61%25.43M-52.69%28.63M99.95%85.35M12.79%44.43M-35.78%46.75M86.49%60.51M-1.64%42.69M-27.03%39.39M
Inventories 51.16%546.13M48.71%503.53M7.42%395.82M2.13%350.11M52.56%361.3M21.37%338.61M31.85%368.47M1.40%342.82M-29.34%236.82M-18.40%278.99M
Receivable financing 8.15%335.48M-38.60%334.49M-34.54%537.03M-40.44%442.23M-45.62%310.19M-14.66%544.79M23.26%820.42M20.15%742.52M28.90%570.37M22.61%638.41M
Assets held for sale --------------67.04M------------------------
Other current assets 252.94%6.68M846.76%72.21M16.59%58.59M-1.94%73.36M124.21%1.89M901.16%7.63M432.27%50.25M162.82%74.81M-79.70%844.36K-81.17%761.79K
Total current assets 2.73%3.73B3.42%3.9B14.50%4.22B8.58%4.05B17.50%3.63B29.45%3.77B28.95%3.69B29.77%3.73B18.53%3.09B9.75%2.91B
Non Current assets
Other non-current financial assets -40.15%11.21M-56.18%11.21M-64.12%11.21M-73.00%11.21M-63.36%18.73M-51.64%25.58M-44.79%31.24M-26.63%41.52M-13.36%51.11M-10.34%52.89M
Long-term equity investment 0.14%4.11M0.14%4.11M0.51%4.11M0.51%4.11M1.01%4.11M1.01%4.11M1.02%4.09M1.02%4.09M0.46%4.07M0.46%4.07M
Fixed assets -----6.01%2.22B-------------0.72%2.36B-----1.66%2.41B-----4.91%2.38B
Constru in process ----111.37%283.85M------------1.91%134.29M----18.86%98.54M----325.12%131.76M
Intangible assets -20.57%170.35M-18.22%176.82M-15.12%190.31M-14.61%197.38M-10.13%214.47M-18.83%216.22M-18.33%224.2M-18.24%231.15M-17.74%238.66M-18.01%266.37M
Development expenditure 9.36%181.5M5.21%177.59M3.66%172.77M3.09%171.7M4.86%165.96M7.73%168.8M9.78%166.67M10.22%166.56M6.98%158.27M7.14%156.68M
Goodwill 0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M
Long deferred expense -21.03%12.07M-20.01%12.85M-20.37%13.62M-21.01%14.4M-8.26%15.28M-8.76%16.06M-10.18%17.11M-8.92%18.23M-20.65%16.66M-19.91%17.6M
Deferred tax assets 56.72%43.04M70.51%47.12M236.25%50.61M189.67%46.22M64.89%27.46M69.07%27.64M-8.76%15.05M-4.82%15.96M-2.67%16.65M-7.39%16.35M
Other non current assets 422.54%105.7M619.92%164.56M616.51%157.45M156.97%55.6M237.42%20.23M178.91%22.86M29.12%21.97M4.42%21.63M-67.45%6M-48.51%8.2M
Total non current assets 3.52%3.17B3.99%3.15B4.19%3.16B0.05%3.07B0.05%3.06B-1.80%3.03B-3.03%3.03B-2.48%3.07B-2.54%3.06B-2.81%3.09B
Total assets 3.09%6.9B3.67%7.05B9.85%7.38B4.73%7.12B8.81%6.7B13.37%6.8B12.25%6.72B12.92%6.8B7.01%6.15B2.91%6B
Liabilities
Current liabilities
Short term loan ----------------------------------0----
Notes payable and accounts payable -28.87%145.27M0.26%230.93M-14.79%253.75M-38.82%228.42M-35.42%204.24M-22.17%230.34M6.10%297.81M3.79%373.36M-3.82%316.24M-0.05%295.97M
-Notes payable ---------------------52.70%7.5M-49.36%11.27M-69.73%11.86M-59.34%17.94M-42.75%15.85M
-Accounts payable -28.87%145.27M3.63%230.93M-11.44%253.75M-36.81%228.42M-31.53%204.24M-20.45%222.84M10.87%286.54M12.77%361.5M4.78%298.31M4.35%280.11M
Contract liabilities 12.82%15.61M-36.70%18.55M-65.65%16.1M-88.29%25.17M-33.31%13.84M29.67%29.31M188.94%46.87M748.11%214.87M49.70%20.75M8.90%22.61M
Salaries payable -44.88%18.08M-51.67%12.49M-60.74%8M-34.04%25.73M28.50%32.8M29.47%25.84M64.52%20.38M60.22%39M36.80%25.53M39.86%19.95M
Taxs payable 7.05%75.79M-22.25%52.9M106.35%59.58M-23.56%70.67M8.36%70.8M-11.40%68.04M-23.76%28.87M84.04%92.44M28.88%65.34M202.13%76.79M
Other payable (including interest and dividends) 6.52%1.18B-1.13%1.24B18.37%1.37B19.88%1.24B26.82%1.11B55.27%1.26B36.46%1.16B36.81%1.03B34.73%872.98M11.55%809.75M
-Dividend payable ----------------------128.61M----------------
-Other payable ----10.13%1.24B------------39.39%1.13B----36.81%1.03B----11.55%809.75M
Hold and for sell liabilities --------------16.55M------------------------
Other current liabilities 12.92%2.02M-36.86%2.4M-65.77%2.09M-88.34%3.26M-33.58%1.79M29.18%3.8M188.94%6.09M748.11%27.93M49.70%2.7M8.90%2.94M
Total current liabilities 0.39%1.44B-3.36%1.56B9.79%1.71B-9.68%1.61B9.75%1.43B31.48%1.61B19.16%1.56B22.59%1.78B0.56%1.3B-11.63%1.23B
Current liabilities
Long term account payable ------0--------------0------0------0
Specific account payable ----0.00%1.93M------------0.00%1.93M----0.00%1.93M----0.00%1.93M
Long term deferred income 68.26%128.92M100.74%156.51M98.08%154.57M60.14%126.16M-12.49%76.62M-11.06%77.97M-12.94%78.03M-12.97%78.78M-3.69%87.55M-4.55%87.66M
Total non current liabilities 66.59%130.84M98.31%158.43M95.72%156.5M58.70%128.08M-12.22%78.54M-10.83%79.89M-12.67%79.96M-12.70%80.71M-3.62%89.48M-4.46%89.59M
Total liabilities 3.83%1.57B1.43%1.72B13.97%1.87B-6.72%1.74B8.34%1.51B28.61%1.69B17.08%1.64B20.48%1.86B0.28%1.39B-11.18%1.32B
Shareholders equity
Paid-in capital -0.48%581.8M-0.48%581.8M0.03%584.75M0.03%584.75M0.00%584.6M1.42%584.6M1.42%584.6M-1.40%584.6M-1.40%584.6M-2.77%576.43M
Capital reserve funds -23.85%92.96M-23.85%92.96M13.92%111.79M13.92%111.79M47.47%122.07M365.07%122.07M273.86%98.13M-42.88%98.13M-52.58%82.78M-84.96%26.25M
Surplus reserve funds 0.00%292.81M0.00%292.81M0.00%292.81M0.00%292.81M0.00%292.81M0.00%292.81M0.00%292.81M-5.79%292.81M-5.79%292.81M-5.79%292.81M
Retained profit 8.08%4.39B7.78%4.3B10.41%4.4B10.62%4.25B10.14%4.06B10.23%3.99B13.24%3.98B12.75%3.84B11.98%3.69B11.46%3.62B
Less:Treasury stock 224.73%210.09M85.48%120M-3.78%62.26M-25.60%48.14M0.00%64.7M--64.7M--64.7M-64.06%64.7M-64.06%64.7M----
Shareholders equity without minority interests 3.02%5.15B4.53%5.15B8.81%5.33B9.23%5.19B9.01%5B9.07%4.93B10.90%4.9B10.45%4.75B9.34%4.59B7.86%4.52B
Minority interests -1.10%185.59M1.29%186.99M0.75%182.64M4.43%187.76M7.25%187.67M9.50%184.61M7.43%181.27M6.80%179.8M4.52%174.98M3.91%168.59M
Total shareholder equity 2.87%5.34B4.42%5.34B8.52%5.51B9.05%5.38B8.95%5.19B9.09%5.11B10.77%5.08B10.31%4.93B9.16%4.76B7.71%4.68B
Total liabilityies and equity 3.09%6.9B3.67%7.05B9.85%7.38B4.73%7.12B8.81%6.7B13.37%6.8B12.25%6.72B12.92%6.8B7.01%6.15B2.91%6B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data